No Data
ALT Altimmune
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Altimmune Company
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Revenue Breakdown
News
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
Congressman Bernie Sanders (I-Vt.) has been known to tussle with public companies over their high prices or anticompetitive behavior, including pharmaceutical companies and their high costs.In his new
Catalyst Watch: Intel's AI Event, Oracle Earnings and CAVA IPO Lockup Expiration
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.Investors are con
Comments



News
Benzinga· 1 min ago

Watching

Earnings win
Moomoo 24/7· 1 min ago

why drop??
Snow Wolf : Shorted! We were close! This one likes to spike $1-$1.50 and drop!